{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:27:28Z","timestamp":1761514048725},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1097\/rlu.0000000000001775","type":"journal-article","created":{"date-parts":[[2017,7,30]],"date-time":"2017-07-30T02:30:08Z","timestamp":1501381808000},"page":"773-775","source":"Crossref","is-referenced-by-count":5,"title":["Adrenocorticotropic Hormone\u2013Secreting Neuroendocrine Tumor of the Rectum Demonstrated on 68Ga-DOTATATE and 18F-FDG PET Imaging"],"prefix":"10.1097","volume":"42","author":[{"given":"Jeremy","family":"Szajer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Yung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Mansberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210204","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2967\/jnumed.116.178095","article-title":"Comparison of the impact of 68Ga-DOTATATE and 18F-FDG PET\/CT on clinical management in patients with neuroendocrine tumors","volume":"58","author":"Panagiotidis","year":"2017","journal-title":"J Nucl Med"},{"key":"R2-10-20210204","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/RLU.0000000000000641","article-title":"Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET\/CT for pulmonary carcinoid","volume":"40","author":"Lococo","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R3-10-20210204","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.2967\/jnumed.114.142224","article-title":"Can complementary 68Ga-DOTATATE and 18F-FDG PET\/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?","volume":"55","author":"Simsek","year":"2014","journal-title":"J Nucl Med"},{"key":"R4-10-20210204","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","article-title":"Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation","volume":"35","author":"Hofman","year":"2015","journal-title":"Radiographics"},{"key":"R5-10-20210204","first-page":"426","article-title":"The value of (68)Ga-DOTATATE PET\/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature","volume":"15","author":"Mojtahedi","year":"2014","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"R6-10-20210204","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12149-013-0718-4","article-title":"Physiological and tumoral uptake of (68)Ga-DOTATATE: standardized uptake values and challenges in interpretation","volume":"27","author":"Kuyumcu","year":"2013","journal-title":"Ann Nucl Med"},{"key":"R7-10-20210204","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s12149-014-0856-3","article-title":"(68)Ga-DOTATATE PET\/CT in the evaluation of patients with neuroendocrine metastatic carcinoma of unknown origin","volume":"28","author":"Alonso","year":"2014","journal-title":"Ann Nucl Med"},{"key":"R8-10-20210204","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/cncr.23469","article-title":"Functional imaging of neuroendocrine tumors with combined PET\/CT using 68Ga-DOTATATE (DOTA-DPhe1, Tyr3-octreotate) and 18F-FDG","volume":"112","author":"Kayani","year":"2008","journal-title":"Cancer"},{"key":"R9-10-20210204","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2967\/jnumed.115.154500","article-title":"Modifying the poor prognosis associated with 18F-FDG-avid NET with peptide receptor chemo-radionuclide therapy (PRCRT)","volume":"56","author":"Hofman","year":"2015","journal-title":"J Nucl Med"},{"key":"R10-10-20210204","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/apt.13697","article-title":"Review article: the investigation and management of rectal neuroendocrine tumours","volume":"44","author":"Basuroy","year":"2016","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:19:46Z","timestamp":1620973186000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201710000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001775","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}